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As a follow-up of a retrospective survey on tick borne-
encephalitis (TBE) in 2008, the European Network for 
Diagnostics of “Imported” Viral Diseases launched a 
new survey in 2010, to collect broader information on 
TBE prevalence between 2007 and 2009 and to observe 
possible changes compared to the previous data. A 
two-part questionnaire was mailed to contact points 
in all European Union (EU) Member States and four 
non-EU countries (Bosnia and Herzegovina, Norway, 
Russia, and Switzerland). The first part was identical 
to the 2008 survey, requesting information on case 
definition, diagnostic methods, investigations regard-
ing tick-transmitted diseases, endemic foci mapping, 
vaccination programmes, and recommendations for 
travellers. The second newly added part, inquired 
about geographic and seasonal distribution of TBE 
cases, imported cases, TBE subtypes, animal cases, 
and prevalence in ticks and wildlife hosts. Of 28 partic-
ipat-ing countries, 16 had TBE as a notifiable disease, 
as in the first survey. In the 2007–2009 period, the 
total number of notified cases (17,818) was lower than 
in 2004–2006 (21,339 cases), also when subtracting 
Russian cases (8,207 vs 9,073 cases respectively). The 
highest reported incidence was 18.5 per 100,000 pop-
ulation in Lithuania in 2009. The 2010 study showed 
that increased numbers of countries used PCR and 
nucleotide sequencing for particular investigations. 
Most countries, however, relied on specific antibody 
detection by enzyme linked immunosorbent assay for 
TBE laboratory diagnosis. Disparities nevertheless 
remained across countries regarding case definitions, 
and surveillance and prevention activities. To under-
stand changing patterns in TBE transmission, surveil-
lance strategies including screening of vector ticks 
and testing of animal hosts should be harmonised and 
done more systematically in Europe. Collected data 
will support rec-ommendations concerning diagnos-
tic and mapping methods, case reporting, vaccination 
programmes and information campaigns.
Introduction 
Tick-borne encephalitis (TBE) is due to a zoonotic arbo-
virus infection of the central nervous system (CNS) 
and affects humans. With an average of about 9,000 
reported cases of TBE per year in Europe and Russia 
between 1990 and 2007, it is the most important tick-
borne viral disease in Eurasia [1-7]. TBE is caused by TBE 
virus, a virus species of the genus Flavivirus within the 
Flaviviridae family, with three subtypes: the European 
subtype, the Siberian sub-type and the Far Eastern sub-
type [8,9], which are associated with varying degrees 
of disease severity [1-3,10-12]. More detailed informa-
tion on the clinical picture, case definition and other 
issues of interest are available in a TBE fact sheet on 
the European Network for Diagnostics of “Imported” 
Viral Diseases (ENIVD) website [http://www.enivd.org] 
or in the 2010 spotlight for tick-borne diseases on the 
European Centre for Disease Prevention and Control 
(ECDC) website [http://ecdc.europa.eu].
In nature, TBE virus is propagated in a cycle involving 
permanently infected ticks and small mammals, espe-
cially rodents. Virus transmission occurs horizontally 
between tick vectors and vertebrate hosts, particularly 
between spring and autumn. In addition, co-feeding of 
infected and non-infected ticks on the same host as 
well as trans-stadial and trans-ovarial transmission of 
the virus, play a major role in virus transmission [13]. 
While most TBE virus infections of humans occur fol-
lowing the bite of an infected tick, alimentary routes of 
TBE virus transmis-sion by raw milk consumption have 
also been described [14-19].
The principal vector of the European TBE virus subtype 
is Ixodes ricinus, and for the two other subtypes I. per-
sulcatus [3,20,21]. Although the virus has been iso-
lated from several other tick species [1], only the two 
mentioned ixodid tick species appear to play an impor-
tant role in virus maintenance [13]. Therefore, the epi-
demiology of TBE is strongly influenced by the ecology 
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and biology of ixodid ticks [2,3,20,21]. Unlike other 
tick-borne diseases, such as Lyme borreliosis, TBE is 
distributed in an endemic pattern of so-called natural 
foci over a wide geographical area covering northern 
Asia, Russia and central Europe. The distribution of 
TBE subtypes is closely related to the presence of the 
respective tick vectors in a certain geo-graphical area 
[2,6,20,21]. Co-circulation of two or all three subtypes 
was demonstrated in the Baltic states and Finland 
[22,23]. 
Countries with high-risk areas, i.e. with an incidence of 
over 10 per 100,000 population, are the Czech Republic, 
Estonia, Latvia, Lithuania, Russia and Slovenia. 
TBE is also an important issue in Germany, Poland, 
Switzerland, Sweden, Finland, Slovakia and Hungary 
[24,25]. Although TBE has a lower public health impact 
in Denmark, France, Greece, Italy, Norway and Turkey, 
new TBE foci or possible occurrence of TBE virus are 
reported in these countries [25-27]. Austria is the only 
country with progressively decreasing incidence rates 
since 1981 due to its vaccination campaign, but the 
occurrence of TBE may be relevant to unvaccinated 
tour-ists [24,25,28]. 
TBE is a growing concern in Europe, as an increase of 
TBE incidence has been observed in some risk areas 
and new foci have appeared in the last decade [29]. But 
the surveillance and notification schemes are not uni-
form, not always mandatory, and may affect the preva-
lence estimates for the disease in certain regions. Main 
problems are the lack of a Europe-wide standard case 
definition, varying diagnostic procedures and wide 
differences in the intensity and quality of national 
surveillance of TBE cases [25,28]. Thus, surveillance 
data from different countries are difficult to compare. 
Furthermore, little is known about the true TBE virus 
prevalence in tick populations or about the circulation 
of new subtypes in Europe.
A first survey was conducted by the ENIVD in 2008 
on surveillance, prevention and labora-tory activi-
ties concerning TBE, with 22 participating countries 
[25]. Although the 2008 study covered a period from 
2004 to 2007, the data recovered in 2007, when the 
respective national programs were ending their annual 
surveillance, were minimal compared to the three con-
secu-tive previous years. Here, we describe the results 
of a second more extended survey launched in 2010 
aimed at collecting broader information on TBE preva-
lence between 2007 and 2009, and also allowing the 
comparison of two three-year intervals, between 2004 
and 2009, to detect possible changes in TBE assess-
ment and prevalence. 
Methods 
To request information on TBE diagnostics, surveil-
lance and prevention activities in national surveil-
lance systems, a two-part questionnaire was mailed 
to contact points in all Member States of the European 
Union (EU) and four non-EU countries (Bosnia and 
Herzegovina, Norway, Russia, and Switzerland) based 
on an ENIVD database of expert microbiologists and 
epidemiologists. The first part of the questionnaire 
was identical to the previous ENIVD-survey in 2008 
[25] asking whether TBE was notifiable, and requesting 
information on annual case numbers, case definition, 
type of diagnostic methods, investigations regarding 
tick-transmitted diseases, mapping of endemic foci, 
vaccination programmes, and recommendations for 
travellers. The second part of the questionnaire was 
designed to collect more information about the recent 
situation for TBE on a more detailed scale with new 
questions as follows:
•	 Did you observe a change in the known geographic 
distribution of TBE in your country? If yes, is the 
range expanding or decreasing? 
•	 Did you register human cases during winter? 
•	 Which TBE subtypes are involved in general? 
•	 Did you register imported cases? 
•	 Do you have reports of clusters of cases? 
•	 Do you have reports of cases in livestock or compan-
ion animals (pets)? 
•	 Do you have information regarding prevalence in 
ticks/wildlife hosts? If yes, for which region? If not, 
do there exist plans to monitor ticks/wildlife hosts 
in the near future? 
All contributors are listed in the acknowledgements 
section. The completed questionnaires were returned 
during the spring trimester of 2010. The TBE case 
numbers for 2009 were added afterwards, in summer 
2010, in order to receive the complete notified data. 
Therefore, the results of this survey reflect national 
surveillance systems and case numbers for TBE up to 
these dates. Bosnia and Herzegovina and Romania did 
not contribute data to some of the re-sults presented 
in this study. As our goal was to obtain an overview 
on the assessment and situation of TBE in Europe, and 
Europe’s eastern geographical frontier is delineated 
by the Ural Mountains in Russia, the TBE situation in 
Russia was surveyed. It is to be noted, however, that 
the Russian data presented here are for the whole 
country, including the non-European parts of Russia. 
Results 
Of 31 contacted countries, 28 (24 EU and four non-EU 
countries) participated in this survey, equivalent to a 
recovery rate of 90% (recovery rate from the first sur-
vey in 2008: 22 of 30 contacted countries, 73%) (Figure 
1). Six additional countries participated compared to 
the first survey and included Bosnia and Herzegovina, 
Bulgaria, Denmark, Malta, Romania, and the United 
Kingdom.
Case reporting
At the time of the survey, TBE cases were mandatorily 
notifiable in 16 of the 28 participating countries (57%). 
No information on this item was given by Romania 
(Figure 1). Of the 16 countries with TBE notification, five 
(Austria, Germany, Hungary, Norway, Slovenia) had a 
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case definition based on clinical criteria and laboratory 
confirmation, five (Czech Republic, Estonia, Finland, 
Greece, Poland) additionally included an epidemio-
logical link (e.g. tick exposure or recent travel in TBE 
endemic area) in the case definition, and the remaining 
six countries had no official or clearly formulated case 
definition (Table 1). During the survey, Finland and 
Sweden reported that their case definitions were still 
under discussion by a Bal-tic/Nordic working group on 
tick-borne diseases since 2007. In comparison to the 
first survey in 2008, changes could be observed for 
Norway now having formulated a case definition; and 
for the Czech Republic, Greece and Poland where an 
epidemiological link has been included into their exist-
ing case definitions.
Although case definitions were provided by ten 
countries, differences still could be seen in the clas-
sification of relevant TBE cases according to clini-
cal symptoms (e.g. classifications in Austria, Czech 
Republic, Hungary, Norway, or Slovenia), as well as in 
the application of laboratory tests for case confirmation 
(Table 1). Commonly, the routine laboratory diagnosis 
of TBE is based on the detection of specific antibod-
ies by enzyme linked immunosorbent assay (ELISA) as 
done in 25 participating countries (96%; first survey in 
2008: 91%). The application of reverse transcriptase-
polymerase chain reaction (RT-PCR) and sequencing 
(SEQ) – which are included for particular investigations 
(e.g. tick/host infectivity studies or severe cases) – has 
dramatically increased in comparison to the first sur-
vey. The RT-PCR is applied by 17 countries (65%; 2008: 
45%) and SEQ by 13 countries (50%; 2008: 1/22, i.e. 
4.5%). Other methods included virus neutralisation 
test (six countries), immunofluorescence assay and 
virus isolation (five countries each), haemagglutination 
inhibition assay (four countries), and complement fixa-
tion test and Western blot (two countries each), respec-
tively. No information on this item was given by Malta 
and the United Kingdom which are both non-endemic 
areas (Table 1). 
Surveillance activities
Information on further investigations regarding tick-
transmitted diseases was provided by 21 countries 
(Table 1). Human survey studies on TBE (11 countries) 
and borreliosis (12 countries) were mainly conducted, 
followed by surveys on other less common tick-trans-
mitted diseases/pathogens like rickettsiosis in seven 
countries; anaplasmosis/ehrlichiosis in four countries; 
Crimean-Congo haemorrhagic fever virus and other 
arboviruses in two countries. Surveys on prevalence of 
TBE virus in tick populations were also performed in 10 
countries and on prevalence of borrelia in 11 countries; 
followed by tick surveys for anaplasma/ehrlichia in 11 
countries; babesia in six countries; rickettsia in four 
countries; Crimean-Congo haemorrhagic fever- and 
louping ill virus each in one country; and only for tick 
density/activity in two countries. Finally, three coun-
tries reported to conduct TBE serosurveys in animals/
livestock. Although most of these investigations are 
based on research funds and are hence not systemati-
cally done, a slight increase of those activities could be 
observed in general compared to the first survey. 
A total of 17 countries provided information on what 
kind of data their TBE risk assessments are based on 
(Table 1). The mapping of risk areas is mainly based on 
the geographical inci-dence of autochthonous clinical 
cases (14 countries) and/or human seroprevalence data 
(four countries), while nine countries also included 
data on infected ticks in the risk assessment, and only 
two countries used data from natural animal reservoirs 
(e.g. rodents). In Belgium, Bulgaria, Denmark, Estonia, 
and Greece epidemiological assessment for mapping 
of TBE risk areas is in progress or planned. 
Tick-borne encephalitis incidence  
and prevalence 
As in the first survey, 16 countries reported to have TBE 
as a notifiable disease. The numbers and incidence 
rates of notified cases in these countries per year are 
shown in Figure 2 (except Greece with no reported TBE 
cases up to date). The overall number of notified cases 
during the currently observed three-year interval (17,818 
cases from 2007 to 2009) decreased in comparison to 
Figure 1
Form of notification for tick-borne encephalitis in 
European countries and Russia participating in the survey, 
2010 (n=28) 
Countries with mandatory tick-borne encephalitis notification, 
n=16
Countries with non-notifiable disease or notification as part of 
general meningitis or encephalitis surveillance, n=11
Country gave no information on this issue

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Annual case numbers and incidence rates per 100,000 population of tick-borne encephalitis, by country where tick-borne 







































































































































































































































































































































































































2004 2005 2006 2007 2008 2009
Greece not included due to no reported tick-borne encephalitis cases up to date.
Numbers in parentheses are the incidence rates per 100,000 population.
The scale for the y-axis differs between each graph.
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the last interval (21,339 cases from 2004 to 2006), also 
when subtracting Rus-sian cases (8,207 vs 9,073 cases 
respectively). Looking at incidence values we cannot 
observe any clear trend as overall incidence rates have 
fluctuated from year to year. These fluctuations may 
well reflect that changes in TBE incidence are due to a 
complex interrelation of several factors, such as social 
(e.g. socio-political changes, human leisure activities), 
ecological (e.g. effect of climate change on vectors dis-
tribution) and/or technological factors (e.g. advanced 
diagnostics and medical awareness). Incidence rates 
were particularly high (over 10.0 per 100,000 popula-
tion), fluctuating with peaks, in four countries: Estonia, 
Latvia, Lithuania and Slovenia. On the other hand, 
incidence rates have been rather low (under 1.0 per 
100,000 population) all throughout the six years of 
the studies in Finland, Germany, Hungary, Norway and 
Poland. The epidemiological and laboratory sources of 
information for the TBE surveillance data are listed in 
Table 2.
None of the previously participating non-endemic 
countries, i.e. Belgium, Greece, Portugal, Spain, and 
the Netherlands became endemic during the period 
between the first and this survey. Also, Bosnia and 
Herzegovina, Malta and the United Kingdom, as new 
participants, did not report any indigenous occurrence 
of TBE. Bulgaria reported one case in 2009, but had 
none in 2007 and 2008 (data not shown). Since Bulgaria 
participated for the first time in our survey, we can-
not determine whether this indicates a new endemic 
country. Belgium, Bosnia and Herzegovina, Bulgaria, 
Greece, Hungary, Malta, Norway, Poland, Portugal, 
Romania, Slovakia, Spain, the Netherlands, and the 
United Kingdom reported no change or no informa-
tion about a change in geographical distribution. The 
remaining 14 countries declared that TBE is expanding 
within their borders (Table 3). The European situation 
with these new endemic areas is roughly depicted in 
Figure 3. 
Summarised, there is an overall expansion in the geo-
graphical range of TBE towards each direction, as well 
as filling in not yet endemic areas within countries.
Together with the particular surveillance activities 
described above, 13 of the participating countries were 
able to trace and report imported TBE cases (Table 3). 
Although in most coun-tries this was a rare event with 
one or only a few cases, this underlines the impor-
tance of travel recommendations. It also reflects an 
enhanced awareness for imported diseases in general 
and the capability to diagnose an imported TBE case in 
particular. 
Clusters of cases were reported from 13 of 21 countries 
responding to this particular question in the survey. 
TBE cases during the winter were reported from nine 
countries, while 13 coun-tries did not observe cases 
during the winter. No information was available from 
the remaining six countries (Table 3). Subtypes dif-
fering from the predominant European subtype (as 
registered in 13 countries) were additionally reported 
from Finland and Estonia (Siberian sub-type), and 
from Russia and Latvia (Siberian and Far Eastern sub-
types). For Lithuania the information for the subtypes 
was not available, unfortunately, because of the geo-
graphic location it would have been interesting to 
learn whether only Siberian or both other subtypes are 
present. For the other countries, which did not provide 
data concerning the subtype involved, we can assume 
with certainty that it is predominantly the European 
subtype (Table 3). 
Animal cases
Cases in animals were reported from Austria, Czech 
Republic, Sweden, and Switzerland but no specif-
ics about the clinical presentation or the animal spe-
cies are provided except for do-mestic pigs in Austria 
[17] and dogs in Sweden (Table 3). Finland and Italy 
reported only antibodies in animals with no correlat-
ing disease. In contrast to these few reports, almost all 
participating countries were investigating TBE in ticks 
or in wild animals or are planning to do so in near future. 
However, as shown in Table 3, many of these investiga-
tions seem to have more local character and are not 
planned for the entire area of the respective country. 
Only Denmark, Estonia, Italy, and Spain are not inves-
tigating ticks and wildlife animals and are not planning 
this, while Belgium, Finland, Slovenia, and Switzerland 
are monitoring the entire country. The remaining coun-
tries are investigating particular regions of interest but 
these studies only provide a patchwork of information, 
not a systematic overview. 
Vaccination policy
Besides Austria, Finland, Germany, Hungary, Latvia, 
Russia, Slovenia, and Switzerland, since the last sur-
vey also Italy recently included TBE vaccination in an 
official governmental vaccination programme under 
certain country-specific conditions. In the remaining 
17 countries, it is available as an optional vaccination, 
partly recommended, but not reimbursed by national 
health systems. No information on this item was given 
by Bosnia and Herzegovina and Romania (Table 1). 
Travel recommendations
A total of 18 countries stated that they had more or less 
official recommendations regarding TBE vaccination for 
people travelling to endemic areas, while the other par-
ticipating countries did not provide information on this 
issue (Table 1). Although the responses to this part of 
the questionnaire suggested that not all contact points 
had interpreted the question in the same way, it can be 
deduced that information for travellers is given for fol-
lowing purposes (updated since the last survey):
(i) Recommendation included in national vaccina-
tion programme for citizens visiting en-demic regions 
(stated by Austria, Germany and Poland);
(ii) Information on the endemic status of a country for 
citizens and visitors, including pre-vention measures 









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Slovakia and Slovenia; and comprehensive information 
in Finland, Sweden and Switzerland); 
(iii) Information on the endemic status of foreign coun-
tries for citizens travelling abroad, including prevention 
measures (stated by Belgium, France, Greece, Norway, 
Portugal and Spain).
Discussion 
Since our first survey in 2008 [25], six additional coun-
tries (Bosnia and Herzegovina, Bul-garia, Denmark, 
Malta, Romania, and the United Kingdom) provided 
data regarding their TBE epidemiological situation, 
which gave a more comprehensive picture for Europe. 
Bosnia and Herzegovina reported that TBE is not of pub-
lic health importance and that the country is only reg-
istering imported cases every year. From Romania we 
know that a regional surveillance of TBE neuroinvasive 
infections has been started in June 2008 by the Public 
Health Institute in Cluj, including patients with an epi-
demiological link (residents of previously confirmed 
endemic areas, tick bite, occupational exposure, or 
consumption of raw milk/milk-products from infected 
animals), but further details were not available. So, 
unfortunately, the TBE epidemiological situation for 
Romania and other eastern European countries, which 
did not participate in this survey, still remains unclear. 
Knowledge about endemic foci is currently almost 
exclusively based on reported human cases. As in 
the first survey, 16 of the 28 participating countries 
reported to have TBE as a notifiable disease. A variety 
of (laboratory) case definitions exists mostly aiming at 
taking the particular level of endemicity into account. 
While about one third of those countries with TBE 
notification use a combination of clinical picture and 
laboratory testing, a further third adds epidemiologi-
cal aspects, while in the remaining third no officially 
approved case definition exists. 
For the latter, it is questionable how valid the number 
of officially recorded TBE cases is. Among these coun-
tries are those with high incidence rates suggesting 
that TBE is a disease “easily” diagnosed by any physi-
cian. We doubt that this procedure is helpful in order 
to precisely estimate cases and consequently to assess 
infection risks in these particular countries. Likewise, 
it would be important to know, who is reporting TBE 
cases in countries where this disease is a rare event 
and on what ground. It is hard to judge if the reported 
numbers reflect the reality. We conclude that having a 
clear standardised case definition for surveillance pur-
poses is a must in reporting numbers of a notifiable 
disease such as TBE regardless whether it is highly 
prevalent or not. For an appropriate collection of epi-
demiological data, minimum criteria for a standardised 
TBE case definition should be to include all relevant 
types of CNS symptomatic (aseptic meningitis, menin-
goencephalitis and/or meningoencephalomyelitis), 
at least laboratory-confirmed by detection of specific 
antibodies in serum or cerebrospinal fluid, in order to 
avoid under-ascertainment of cases. 
In comparison to the last survey, the number of coun-
tries using molecular diagnostics has increased mark-
edly with more than half of the countries using PCR 
techniques and nucleotide sequencing. RT-PCR meth-
ods can be of great diagnostic value in the early diag-
nosis of TBE and in the discrimination among virus 
subtypes, but only if the patient is hospitalised dur-
ing the febrile first (viremic) phase of infection [35]. 
However, as outlined in Table 1 molecular diagnostic 
methods are mainly used for research purposes and 
not for clinical diagnostics. A former external quality 
assurance (EQA) showed that RT-PCRs used in labora-
tories do not discriminate between TBE virus subtypes 
[36]. Co-circulation of Siberian and European TBE virus 
subtypes were reported from Finland and Estonia, and 
co-circulation of all three subtypes is known to occur in 
Russia and Latvia. This has to be taken into account in 
these countries. 
Some recent reports from single countries provide 
good data and strong evidence for a change (expan-
sion) in geographical distribution of TBE [25-27] but in 
most European countries similar assumptions are just 
Figure 3
Areas of known occurrence of tick-borne encephalitis in 
Europe, 2010
Data of each country surveyed were transferred to the 
geographical map of Europe with red showing known TBE virus-
endemic areas. 
Data from the Crimea peninsula [31,32] and from Albania [33,34] 
were taken from older maps and the literature, and are not based 
on our survey data. 
Known TBE virus-endemic areas
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a guess, so the rationale for the second part of our 
questionnaire was to get solid, first hand data from 
European countries that may relate to travel, climate 
change and similar. Many participating countries pro-
vided detailed description of new endemic areas which 
will be a great basis for a TBE atlas we intend to create 
in the near future.
From an epidemiological point of view, clusters are 
more reported cases than average and expected by 
chance, in a given time period (although this is not 
defined) in a certain area. As such, they are an indica-
tor of unusual transmission patterns or other reasons 
leading to more cases than “normal”. Since we have 
not defined the term cluster in our questionnaire, we 
assume that contact points have interpreted this dif-
ferently. Alimentary infection is well known leading to 
such clusters and three countries reported such events 
during the observation period [17-19]. The other clus-
ters may also relate to an undiscovered alimentary 
source or may relate to a natural focus with high preva-
lence of TBE virus in ticks and a high local transmission 
(e.g. an attractive and highly frequented recreational 
area). 
Inactivated vaccines are available to prevent TBE in 
humans and many studies have demon-strated their 
safety and efficacy [37]. Consequently, the vaccine 
coverage has a major influence on disease occurrence. 
Calculation of vaccination rates is based on sold vac-
cine doses per year and country, but the true protec-
tion rate depends on the correct basic immunisation 
scheme which includes three injections for each indi-
vidual. Thus, the number of sold vaccine doses does 
not reflect directly the percentage of correctly vac-
cinated and thus protected persons. So, caution is 
necessary when, for 11 of the participating countries, 
the percentage of vaccine coverage is compared with 
incidence (personal communication, Peter Gerold, 
Baxter, 17 August 2010) [29]. In fact, such comparison 
would only be useful in a situation of similar incidence 
rates but different percentages of vaccine coverage or 
vice versa. Nevertheless, the well known example of 
Austria with a high prevalence of TBE virus has by far 
the highest vaccine coverage (88% of the total popula-
tion have a history of TBE vaccination) and an incidence 
below 1 per 100,000 population. Using the neighbour-
ing Czech Republic (16% vac-cine coverage, incidence 
7.8 per 100,000 population) and Slovenia (12%, 13.1 
per 100,000 population) provides strong evidence for 
the negative correlation of vaccination and incidence. 
However, Slovakia (1%, 1.3 per 100,000 population) 
would argue against it, clearly showing that a com-
parison is not useful without knowing the prevalence 
in each country. In light of the increasing frequency of 
reported imported and travel associated cases of TBE, 
more emphasis has to be put on educating the popula-
tion in endemic areas as well as providing travel recom-
mendation that certainly include vaccination [29,38]. 
The participating countries mainly applied the surveil-
lance data from clinical cases as an indicator for pre-
dicting endemic foci and for recommending preventive 
measures. Due to the fact that we observed TBE cases 
in winter, recognised imported cases all over Europe, 
and wit-nessed a geographical expansion within 
known endemic areas, as well as new spread outside 
the known foci, epidemiology of TBE seems to become 
more complex than previously thought. In order to 
understand the changing patterns in TBE transmis-
sion we strongly recommend putting more emphasis in 
developing new surveillance strategies. These should 
include screening of vector ticks by RT-PCR in sus-
pected foci but more importantly the serological test-
ing of animals (wildlife, livestock and companion) for 
prevalence studies of TBE virus (and other important 
tick-borne diseases). Some of the participating coun-
tries started such programmes, but these should be 
harmonised and done more systematically on the Euro-
pean level. 
The international awareness for TBE is on the rise, and 
at EU level, TBE is considered of high relevance and a 
series of activities have been launched with the goal 
of improving awareness of this tick-transmissible dis-
ease [7]. Our survey contributes to this end by provid-
ing detailed information concerning TBE epidemiology 
for most European countries. The results of our study 
will help to develop further recommendations for the 
standardisation and quality control in TBE diagnostics, 
surveillance and prevention activities
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